Lutein and antioxidants in the prevention of age-related macular degeneration;Lutein und Antioxidantien zur Prävention der AMD

Ophthalmologe

Volumn 105, Issue 1, 2008, Pages 37-45

  Rehak, M ^a   Fric, E ^b   Wiedemann, P ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Age related macular degeneration; Antioxidants; Lutein; Prevention

Indexed keywords

ANTIOXIDANT; XANTHOPHYLL;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; GERMANY; HUMAN; META ANALYSIS; RETINA MACULA DEGENERATION; TREATMENT OUTCOME;

ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; GERMANY; HUMANS; LUTEIN; MACULAR DEGENERATION; PHYSICIAN'S PRACTICE PATTERNS; TREATMENT OUTCOME;

EID: 39149134294     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-007-1602-1     Document Type: Article

References (79)

1. Age-Related Eye Disease Study Research Group (1996) Multicenter ophthalmic and nutritional age-related macular degeneration study-part 1: design, subjects and procedures. J Am Optom Assoc 67: 12-29
2. Age-Related Eye Disease Study Research Group (2001) AREDS Report No.8 - A randomized, Placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119: 1417-1436
3. Age-Related Eye Disease Study Research Group (2004) AREDS Report No.18 - A simplified severity scale for age-related macular degeneration. Arch Ophthalmol 123: 1570-1574
4. Ahmend SS, McGregor NL, Marcus DM (2005) The macular Xanthophylls. Surv Ophthalmol 50: 183-193
5. Alves-Rodrigues A, Shao A (2004) The science behind Lutein. Toxicol Lett 150: 57-83
6. Augood CA, Jong PT de, Chakravathy U et al. (2006) Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EU-REYE). Arch Ophthalmol 124: 529-535
7. Augustin AJ, Schmidt-Erfurth U (2002) Critical comments on the ARED study. Ophthalmologe 99: 299-300
8. Beatty S, Koh H, Phil M et al. (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45: 115-134
9. Beatty S, Murray IJ, Henson DB et al. (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42: 439-446
10. Berendschot TT, Willemse-Assink JJ, Bastiaanse M et al. (2002) Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 43: 1928-1932
11. Bernstein PS, Zhao DY, Wintch SW et al. (2002) Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109: 1780-1787
12. Biesalski HH (2007) Antioxidanzien - kein Grund zur Neubewertung. Ophthalmologe (online 27.6.2007; 10.1007/s00347-007-1579-9)
13. Bird AC, Bressler NM, Bressler SB et al. (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The international ARM Epidemiological Study Group. Surv Ophthalmol 39: 367-374
14. Bjelakovic G, Nikolova D, Gluud LL et al. (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. JAMA 297: 842-857
15. Bone RA, Landrum JT (1984) Macular pigment in Henle fiber membranes: a model for Haidinger's brushes. Vision Res 24: 103-108
16. Bone RA, Landrum JT, Fernandez et al. (1988) Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 29: 843-849
17. Bone RA, Landrum JT, Guerra LH et al. (2003) Lutein and zeaxanthin dietary supplements raise macular pigment density and serum contcentration of these carotenoids in humans. J Nutr 133: 992-998
18. Cardinault N, Abalain JH, Sairafi B et al. (2005) Lycopene but not lutein nor zeaxanthin decreases in serum and lipoproteins in age-related macular degeneration patients. Clin Chim Acta 357: 34-42
19. Cho E, Hung S, Willett WC et al. (2001) Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr 73: 209-218
20. Cho E, Seddon JM, Rosner WCW et al. (2004) Prospective study of intake of fruits, vegetables, vitamins and carotenoids and risk of age-related maculopathy. Arch Ophthalmol 122: 883-892
21. Ciulla TA, Curran-Celantano J, Cooper DA (2001) Macular pigment optical density in a midwestern sample. Ophthalmology 108: 730-737
22. Connor KM, Sangiovanni JP, Lofqvist C et al. (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13: 868-873
23. Cruickshanks KJ, Klein R, Klein BEK et al. (1995) Sunlight and age-related macular degeneration. Arch Ophthalmol 111: 514-518
24. Dasch B, Fuhs A, Schmidt J (2005) Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS). Graefes Arch Clin Exp Ophthalmol 243: 1028-1035
25. Delcourt C, Diaz JL, Ponton-Sanchez A et al. (1998) Smoking and age-related macular degeneration. Arch Ophthalmol 116: 1031-1035
26. Delcourt C, Cristol JP, Tessier F et al. (1999) Age-related degeneration and antioxidant status in the POLA Study. Arch Ophthalmol 117: 1384-1390
27. Doenecke D, Koolman J, Fuchs G et al. (2005) Karlsons Biochemie und Pathobiochemie. Thieme, Stuttgart New York, S 336-338
28. Edwards AO, Ritter R 3rd, Abel KJ et al. (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421-424
29. Evans JR (2001) Risk factors for age-related macular degeneration. Prog Retin Eye Res 20: 227-253
30. Evans JR (2006) Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 19: CD000254
31. Evans JR, Fletcher AE, Wormald RPL (2005) 28000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 89: 550-553
32. Flood V, Smith W, Wang JJ et al. (2002) Dietary antioxidant intake and incidence of early age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 109: 2272-2278
33. Garrett SK, Thomas AP, Cicuttini F et al. (2000) Community-based recruitment strategies for a longitudinal interventional study: the VECAT experience. J Clin Epidemiol 53: 541-548
34. Hammond BR, Caruso-Avery M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41: 1492-1497
35. Hammond BR Jr, Fuld K, Curran-Celentano J (1995) Macular pigment density in monozygotic twins. Invest Ophthalmol Vis Sci 36: 2531-2541
36. Hammond BR Jr, Johnson EJ, Russel R et al. (1997) Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38: 1795-1801
37. Hayes KC (1974) Retina degeneration in monkeys induced by deficiency of vitamin E or A. Invest Ophthalmol Vis Sci 13: 499-510
38. Hogg R, Chakravathy U (2004) AMD and micronutrient antioxidants. Curr Eye Res 29: 387-401
39. Hodge WG, Schachter HM, Barnes D et al. (2006) Efficacy of ω-3 fatty acids in preventing age-related macular degeneration. Ophthalmology 113: 1165-1173
40. Holz FG, Wolfensberger TJ, Piguet B et al. (1993) Oral zinc and the second second eye in age-related macular degeneration: A double blind study. Ger J Ophthalmol 2: 391
41. Jahn C, Brinkmann C, Mößner A et al. (2006) Jahreszeitliche Schwankungen und Einfluss der Ernährung auf die makuläre Pigmentdichte. Ophthalmologe 103: 136-140
42. Johnson EJ (2005) Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr Rev 63: 9-15
43. Kahn HA, Leibowitz HM, Ganley JP et al. (1977) The Framingham Eye Study. II. association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol 106: 33-41
44. Kaiser HJ, Flammer J, Stumpfig D et al. (1995) Visaline in the treatment of age-related macular degeneration: A pilot study. Ophthalmologica 209: 302-305
45. Klein R, Davis MD, Magli YL et al. (1991) Wisconsin age-related maculopathy grading system. Ophthalmology 98: 1128-1134
46. Klein R, Klein BE, Linton KL (1992) Prevalence of age-related maculopathy. The Beaver Dam Study. Ophthalmology 99: 933-943
47. Landrum JT, Bone RA, Joa H et al. (1997) A one year study of macular pigment: The effect of 140 days of lutein supplement. Exp Eye Res 65: 57-62
48. Mares-Perlman JA, Brady WE, Klein R et al. (1995) Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 113: 1518-1523
49. Mares-Perlman JA, Fisher AI, Palta M et al. (2001) Lutein and Zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol 153: 424-432
50. Mares-Perlman JA, Millen AE, Ficek TL et al. (2002) The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J Nutr 132: 518S-524S
51. Mitchell P, Wang JJ, Smith W et al. (2002) Smoking and the 5-year incidence of age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol 120: 1357-1363
52. Newsome DA, Swartz M, Leone NC et al. (1988) Oral zinc in macular degeneration. Arch Ophthalmol 106: 192-198
53. Omenn GS, Goodman GE, Thornquist MD et al. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334: 1150-1155
54. Pauleikhoff D, Koch JM (1995) Prevalence of age-related macular degeneration. Curr Opin Ophthalmol 6: 51-56
55. Richer S (1996) Multicenter ophthalmic and nutritional age-related macular degeneration study-part 2: antioxidant intervention and conclusions. J Am Optom Assoc 67: 30-49
56. Richer SP (1993) Is there a prevention and treatment strategy for macular degeneration? J Am Optom Assoc 64: 838-850
57. Richer SP, Stiles W, Statkute L et al. (2004) Double-masked, placebo-controlled, randomized trial of Lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75: 216-230
58. Robman LD, Tikellis G, Garrett SK (1999) Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study. Aust N Z J Ophthalmol 27: 410-416
59. Scholl HP, Fleckenstein M, Issa PC et al. (2007) An update on the genetics of age-related macular degeneration. Mol Vis 13: 196-205
60. Schmidt-Erfurth U (2005) Nutrition and retina. Dev Ophthalmol 38: 120-147
61. Schrader WF (2006) Altersbedingte Makuladegeneration. Sozioökonomische Zeitbombe in der alternden Gesellschaft. Ophthalmologe 103: 742-748
62. Seddon JM, Alani UA, Sperduto RD et al. (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 272: 1413-1420
63. Seigel D (2002) AREDS investigators distort findings. Arch Ophthalmol 120: 100-101
64. Snellen EL, Verbeek AL, Van Den Hoogen GW (2002) Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand 80: 368-371
65. Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62: 1448S-1461S
66. Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25: 674-683
67. Stur M, Tittl M, Reitner A et al. (1996) Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 37: 1225-1235
68. Suner IJ, Espinosa-Heidmann DG, Marin-Castano ME, Hernandez et al. (2004) Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 45: 311-317
69. Taylor HR, West S, Munoz B et al. (1994) The long-term effects of visible light on the eye. Arch Ophthalmol 110: 99-104
70. Tan JS, Mitchell P, Smith W et al. (2007) Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology114: 143-150
71. Thomson LR, Toyoda Y, Langner A et al. (2002) Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci 43: 3538-3549
72. Trieschmann M, Beatty S, Nolan JM et al. (2007) Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: The LUNA study. Exp Eye Res 84: 718-28; Epub 2006 Dec
73. VandenLagenberg GM, Mares-Perlman JA, Klein R et al. (1998) Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol 148: 204-214
74. Leeuwen R van, Boekhoorn S, Vingerling JR et al. (2005) Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA 294: 3101-3107
75. Vingerling JR, Dielemans I, Hofman A et al. (1995) The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102: 205-210
76. Wald G (1949) The photochemistry of vision. Doc Ophthalmol 3: 94-137
77. Werner JS, Donnelly SK, Kliegl R (1987) Aging and human macular pigment density: appended with translations from the work of Max Schultze and Ewald Hering. Vision Res 27: 257-268
78. Wooten BR, Hammond BR (2002) Macular pigment: influences on visual acuity and visibility. Prog Retin Eye Res 21: 225-240
79. Zarbin MA (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122: 598-6144